APO Research
Talk to an analyst

APO RESEARCH · REPORT

PROTAC Technology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PROTAC Technology Market Analysis and Forecast 2026-2032

1 May 2026249 pages

Choose your research edition.

Industry ResearchPROTAC Technology Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal PROTAC Technology Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal PROTAC Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PROTAC Technology Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal PROTAC Technology Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global PROTAC Technology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for PROTAC Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PROTAC Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PROTAC Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PROTAC Technology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of PROTAC Technology include Arvinas, Captor therapeutics, Pfizer, Amgen, Oerth Bio, Bayer, Kymera, Nurix and C4 Therapeutics, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for PROTAC Technology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PROTAC Technology, also provides the revenue of main regions and countries. Of the upcoming market potential for PROTAC Technology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PROTAC Technology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PROTAC Technology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for PROTAC Technology revenue, projected growth trends, production technology, application and end-user industry.

PROTAC Technology Segment by Company

Arvinas

Captor therapeutics

Pfizer

Amgen

Oerth Bio

Bayer

Kymera

Nurix

C4 Therapeutics, Inc.

Astellas Pharma Inc.

AbbVie

Kaituo Pharmaceutical

Betta Pharmaceuticals

Hengrui Medicine

BeiGene

Haichuang Pharmaceutical

East China Pharmaceutical Group

PROTAC Technology Segment by Type

Based on CRBN

Based on VHL

PROTAC Technology Segment by Application

Breast Cancer

Prostate Cancer

Colorectal Cancer

Pancreatic Cancer

Lymphoma

Androgenic Alopecia

Others

PROTAC Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PROTAC Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PROTAC Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PROTAC Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of PROTAC Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of PROTAC Technology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PROTAC Technology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PROTAC Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Based on CRBN Major Player Table 3. Based on VHL Major Player Table 4. Global PROTAC Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Breast Cancer Major Player Table 6. Prostate Cancer Major Player Table 7. Colorectal Cancer Major Player Table 8. Pancreatic Cancer Major Player Table 9. Lymphoma Major Player Table 10. Androgenic Alopecia Major Player Table 11. Others Major Player Table 12. PROTAC Technology Industry Trends Table 13. PROTAC Technology Industry Drivers Table 14. PROTAC Technology Industry Opportunities and Challenges Table 15. PROTAC Technology Industry Restraints Table 16. Global PROTAC Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global PROTAC Technology Market Size by Region (2021-2026) & (US$ Million) Table 18. Global PROTAC Technology Market Share by Region (2021-2026) Table 19. Global PROTAC Technology Market Size by Region (2027-2032) & (US$ Million) Table 20. Global PROTAC Technology Market Share by Region (2027-2032) Table 21. Global PROTAC Technology Revenue by Players (US$ Million) & (2021-2026) Table 22. Global PROTAC Technology Revenue Market Share by Players (2021-2026) Table 23. Global PROTAC Technology Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global PROTAC Technology Key Players Headquarters & Area Served Table 25. Global PROTAC Technology Players, Product Type & Application Table 26. Global PROTAC Technology Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global PROTAC Technology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global PROTAC Technology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 31. Global PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 32. Global PROTAC Technology Revenue Market Share by Type (2021-2026) Table 33. Global PROTAC Technology Revenue Market Share by Type (2027-2032) Table 34. Global PROTAC Technology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 36. Global PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 37. Global PROTAC Technology Revenue Market Share by Application (2021-2026) Table 38. Global PROTAC Technology Revenue Market Share by Application (2027-2032) Table 39. Arvinas Company Information Table 40. Arvinas Business Overview Table 41. Arvinas PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Arvinas PROTAC Technology Product Portfolio Table 43. Arvinas Recent Development Table 44. Captor therapeutics Company Information Table 45. Captor therapeutics Business Overview Table 46. Captor therapeutics PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Captor therapeutics PROTAC Technology Product Portfolio Table 48. Captor therapeutics Recent Development Table 49. Pfizer Company Information Table 50. Pfizer Business Overview Table 51. Pfizer PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Pfizer PROTAC Technology Product Portfolio Table 53. Pfizer Recent Development Table 54. Amgen Company Information Table 55. Amgen Business Overview Table 56. Amgen PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Amgen PROTAC Technology Product Portfolio Table 58. Amgen Recent Development Table 59. Oerth Bio Company Information Table 60. Oerth Bio Business Overview Table 61. Oerth Bio PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Oerth Bio PROTAC Technology Product Portfolio Table 63. Oerth Bio Recent Development Table 64. Bayer Company Information Table 65. Bayer Business Overview Table 66. Bayer PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Bayer PROTAC Technology Product Portfolio Table 68. Bayer Recent Development Table 69. Kymera Company Information Table 70. Kymera Business Overview Table 71. Kymera PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Kymera PROTAC Technology Product Portfolio Table 73. Kymera Recent Development Table 74. Nurix Company Information Table 75. Nurix Business Overview Table 76. Nurix PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Nurix PROTAC Technology Product Portfolio Table 78. Nurix Recent Development Table 79. C4 Therapeutics, Inc. Company Information Table 80. C4 Therapeutics, Inc. Business Overview Table 81. C4 Therapeutics, Inc. PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. C4 Therapeutics, Inc. PROTAC Technology Product Portfolio Table 83. C4 Therapeutics, Inc. Recent Development Table 84. Astellas Pharma Inc. Company Information Table 85. Astellas Pharma Inc. Business Overview Table 86. Astellas Pharma Inc. PROTAC Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Astellas Pharma Inc. PROTAC Technology Product Portfolio Table 88. Astellas Pharma Inc. Recent Development Table 89. AbbVie Company Information Table 90. AbbVie Business Overview Table 91. AbbVie PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. AbbVie PROTAC Technology Product Portfolio Table 93. AbbVie Recent Development Table 94. Kaituo Pharmaceutical Company Information Table 95. Kaituo Pharmaceutical Business Overview Table 96. Kaituo Pharmaceutical PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Kaituo Pharmaceutical PROTAC Technology Product Portfolio Table 98. Kaituo Pharmaceutical Recent Development Table 99. Betta Pharmaceuticals Company Information Table 100. Betta Pharmaceuticals Business Overview Table 101. Betta Pharmaceuticals PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Betta Pharmaceuticals PROTAC Technology Product Portfolio Table 103. Betta Pharmaceuticals Recent Development Table 104. Hengrui Medicine Company Information Table 105. Hengrui Medicine Business Overview Table 106. Hengrui Medicine PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Hengrui Medicine PROTAC Technology Product Portfolio Table 108. Hengrui Medicine Recent Development Table 109. BeiGene Company Information Table 110. BeiGene Business Overview Table 111. BeiGene PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. BeiGene PROTAC Technology Product Portfolio Table 113. BeiGene Recent Development Table 114. Haichuang Pharmaceutical Company Information Table 115. Haichuang Pharmaceutical Business Overview Table 116. Haichuang Pharmaceutical PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Haichuang Pharmaceutical PROTAC Technology Product Portfolio Table 118. Haichuang Pharmaceutical Recent Development Table 119. East China Pharmaceutical Group Company Information Table 120. East China Pharmaceutical Group Business Overview Table 121. East China Pharmaceutical Group PROTAC Technology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. East China Pharmaceutical Group PROTAC Technology Product Portfolio Table 123. East China Pharmaceutical Group Recent Development Table 124. North America PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 125. North America PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 126. North America PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 127. North America PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 128. North America PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America PROTAC Technology Revenue by Country (2021-2026) & (US$ Million) Table 130. North America PROTAC Technology Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe PROTAC Technology Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe PROTAC Technology Revenue by Country (US$ Million) & (2027-2032) Table 138. China PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 139. China PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 140. China PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 141. China PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia PROTAC Technology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia PROTAC Technology Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia PROTAC Technology Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA PROTAC Technology Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA PROTAC Technology Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA PROTAC Technology Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA PROTAC Technology Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA PROTAC Technology Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA PROTAC Technology Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. PROTAC Technology Image Figure 2. Global PROTAC Technology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PROTAC Technology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Based on CRBN Image Figure 5. Based on VHL Image Figure 6. Global PROTAC Technology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global PROTAC Technology Market Size Share 2021 VS 2025 VS 2032 Figure 8. Breast Cancer Image Figure 9. Prostate Cancer Image Figure 10. Colorectal Cancer Image Figure 11. Pancreatic Cancer Image Figure 12. Lymphoma Image Figure 13. Androgenic Alopecia Image Figure 14. Others Image Figure 15. Global PROTAC Technology Market Size (US$ Million) & (2021-2032) Figure 16. Global PROTAC Technology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global PROTAC Technology Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global PROTAC Technology Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global PROTAC Technology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global PROTAC Technology Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global PROTAC Technology Revenue Market Share by Type (2021-2032) Figure 23. Global PROTAC Technology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global PROTAC Technology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global PROTAC Technology Revenue Market Share by Application (2021-2032) Figure 26. North America PROTAC Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America PROTAC Technology Revenue Share by Type (2021-2032) Figure 28. North America PROTAC Technology Revenue Share by Application (2021-2032) Figure 29. North America PROTAC Technology Revenue Share by Country (2021-2032) Figure 30. United States PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe PROTAC Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe PROTAC Technology Revenue Share by Type (2021-2032) Figure 35. Europe PROTAC Technology Revenue Share by Application (2021-2032) Figure 36. Europe PROTAC Technology Revenue Share by Country (2021-2032) Figure 37. Germany PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China PROTAC Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China PROTAC Technology Revenue Share by Type (2021-2032) Figure 47. China PROTAC Technology Revenue Share by Application (2021-2032) Figure 48. Asia PROTAC Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia PROTAC Technology Revenue Share by Type (2021-2032) Figure 50. Asia PROTAC Technology Revenue Share by Application (2021-2032) Figure 51. Asia PROTAC Technology Revenue Share by Region (2021-2032) Figure 52. Japan PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA PROTAC Technology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA PROTAC Technology Revenue Share by Type (2021-2032) Figure 60. SAMEA PROTAC Technology Revenue Share by Application (2021-2032) Figure 61. SAMEA PROTAC Technology Revenue Share by Country (2021-2032) Figure 62. Brazil PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt PROTAC Technology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Based on CRBN
  • Based on VHL
Applications
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Lymphoma
  • Androgenic Alopecia
  • Others
Companies covered
  • Arvinas
  • Captor therapeutics
  • Pfizer
  • Amgen
  • Oerth Bio
  • Bayer
  • Kymera
  • Nurix
  • C4 Therapeutics, Inc.
  • Astellas Pharma Inc.
  • AbbVie
  • Kaituo Pharmaceutical
  • Betta Pharmaceuticals
  • Hengrui Medicine
  • BeiGene
  • Haichuang Pharmaceutical
  • East China Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PROTAC Technology Market by Type
  3. 1.2.1 Global PROTAC Technology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Based on CRBN
  5. 1.2.3 Based on VHL
  6. 1.3 PROTAC Technology Market by Application
  7. 1.3.1 Global PROTAC Technology Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Breast Cancer
  9. 1.3.3 Prostate Cancer
  10. 1.3.4 Colorectal Cancer
  11. 1.3.5 Pancreatic Cancer
  12. 1.3.6 Lymphoma
  13. 1.3.7 Androgenic Alopecia
  14. 1.3.8 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 PROTAC Technology Market Dynamics
  1. 2.1 PROTAC Technology Industry Trends
  2. 2.2 PROTAC Technology Industry Drivers
  3. 2.3 PROTAC Technology Industry Opportunities and Challenges
  4. 2.4 PROTAC Technology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global PROTAC Technology Market Perspective (2021-2032)
  2. 3.2 Global PROTAC Technology Growth Trends by Region
  3. 3.2.1 Global PROTAC Technology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PROTAC Technology Market Size by Region (2021-2026)
  5. 3.2.3 Global PROTAC Technology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global PROTAC Technology Revenue by Players
  2. 4.1.1 Global PROTAC Technology Revenue by Players (2021-2026)
  3. 4.1.2 Global PROTAC Technology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global PROTAC Technology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PROTAC Technology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global PROTAC Technology Key Players Headquarters & Area Served
  7. 4.4 Global PROTAC Technology Players, Product Type & Application
  8. 4.5 Global PROTAC Technology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global PROTAC Technology Market CR5 and HHI
  11. 4.6.3 2025 PROTAC Technology Tier 1, Tier 2, and Tier 3
5 PROTAC Technology Market Size by Type
  1. 5.1 Global PROTAC Technology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global PROTAC Technology Revenue by Type (2021-2032)
  3. 5.3 Global PROTAC Technology Revenue Market Share by Type (2021-2032)
6 PROTAC Technology Market Size by Application
  1. 6.1 Global PROTAC Technology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global PROTAC Technology Revenue by Application (2021-2032)
  3. 6.3 Global PROTAC Technology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Arvinas
  2. 7.1.1 Arvinas Company Information
  3. 7.1.2 Arvinas Business Overview
  4. 7.1.3 Arvinas PROTAC Technology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Arvinas PROTAC Technology Product Portfolio
  6. 7.1.5 Arvinas Recent Developments
  7. 7.2 Captor therapeutics
  8. 7.2.1 Captor therapeutics Company Information
  9. 7.2.2 Captor therapeutics Business Overview
  10. 7.2.3 Captor therapeutics PROTAC Technology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Captor therapeutics PROTAC Technology Product Portfolio
  12. 7.2.5 Captor therapeutics Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer PROTAC Technology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer PROTAC Technology Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Amgen
  20. 7.4.1 Amgen Company Information
  21. 7.4.2 Amgen Business Overview
  22. 7.4.3 Amgen PROTAC Technology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Amgen PROTAC Technology Product Portfolio
  24. 7.4.5 Amgen Recent Developments
  25. 7.5 Oerth Bio
  26. 7.5.1 Oerth Bio Company Information
  27. 7.5.2 Oerth Bio Business Overview
  28. 7.5.3 Oerth Bio PROTAC Technology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Oerth Bio PROTAC Technology Product Portfolio
  30. 7.5.5 Oerth Bio Recent Developments
  31. 7.6 Bayer
  32. 7.6.1 Bayer Company Information
  33. 7.6.2 Bayer Business Overview
  34. 7.6.3 Bayer PROTAC Technology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bayer PROTAC Technology Product Portfolio
  36. 7.6.5 Bayer Recent Developments
  37. 7.7 Kymera
  38. 7.7.1 Kymera Company Information
  39. 7.7.2 Kymera Business Overview
  40. 7.7.3 Kymera PROTAC Technology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kymera PROTAC Technology Product Portfolio
  42. 7.7.5 Kymera Recent Developments
  43. 7.8 Nurix
  44. 7.8.1 Nurix Company Information
  45. 7.8.2 Nurix Business Overview
  46. 7.8.3 Nurix PROTAC Technology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nurix PROTAC Technology Product Portfolio
  48. 7.8.5 Nurix Recent Developments
  49. 7.9 C4 Therapeutics, Inc.
  50. 7.9.1 C4 Therapeutics, Inc. Company Information
  51. 7.9.2 C4 Therapeutics, Inc. Business Overview
  52. 7.9.3 C4 Therapeutics, Inc. PROTAC Technology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 C4 Therapeutics, Inc. PROTAC Technology Product Portfolio
  54. 7.9.5 C4 Therapeutics, Inc. Recent Developments
  55. 7.10 Astellas Pharma Inc.
  56. 7.10.1 Astellas Pharma Inc. Company Information
  57. 7.10.2 Astellas Pharma Inc. Business Overview
  58. 7.10.3 Astellas Pharma Inc. PROTAC Technology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Astellas Pharma Inc. PROTAC Technology Product Portfolio
  60. 7.10.5 Astellas Pharma Inc. Recent Developments
  61. 7.11 AbbVie
  62. 7.11.1 AbbVie Company Information
  63. 7.11.2 AbbVie Business Overview
  64. 7.11.3 AbbVie PROTAC Technology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AbbVie PROTAC Technology Product Portfolio
  66. 7.11.5 AbbVie Recent Developments
  67. 7.12 Kaituo Pharmaceutical
  68. 7.12.1 Kaituo Pharmaceutical Company Information
  69. 7.12.2 Kaituo Pharmaceutical Business Overview
  70. 7.12.3 Kaituo Pharmaceutical PROTAC Technology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Kaituo Pharmaceutical PROTAC Technology Product Portfolio
  72. 7.12.5 Kaituo Pharmaceutical Recent Developments
  73. 7.13 Betta Pharmaceuticals
  74. 7.13.1 Betta Pharmaceuticals Company Information
  75. 7.13.2 Betta Pharmaceuticals Business Overview
  76. 7.13.3 Betta Pharmaceuticals PROTAC Technology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Betta Pharmaceuticals PROTAC Technology Product Portfolio
  78. 7.13.5 Betta Pharmaceuticals Recent Developments
  79. 7.14 Hengrui Medicine
  80. 7.14.1 Hengrui Medicine Company Information
  81. 7.14.2 Hengrui Medicine Business Overview
  82. 7.14.3 Hengrui Medicine PROTAC Technology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hengrui Medicine PROTAC Technology Product Portfolio
  84. 7.14.5 Hengrui Medicine Recent Developments
  85. 7.15 BeiGene
  86. 7.15.1 BeiGene Company Information
  87. 7.15.2 BeiGene Business Overview
  88. 7.15.3 BeiGene PROTAC Technology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 BeiGene PROTAC Technology Product Portfolio
  90. 7.15.5 BeiGene Recent Developments
  91. 7.16 Haichuang Pharmaceutical
  92. 7.16.1 Haichuang Pharmaceutical Company Information
  93. 7.16.2 Haichuang Pharmaceutical Business Overview
  94. 7.16.3 Haichuang Pharmaceutical PROTAC Technology Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Haichuang Pharmaceutical PROTAC Technology Product Portfolio
  96. 7.16.5 Haichuang Pharmaceutical Recent Developments
  97. 7.17 East China Pharmaceutical Group
  98. 7.17.1 East China Pharmaceutical Group Company Information
  99. 7.17.2 East China Pharmaceutical Group Business Overview
  100. 7.17.3 East China Pharmaceutical Group PROTAC Technology Revenue and Gross Margin (2021-2026)
  101. 7.17.4 East China Pharmaceutical Group PROTAC Technology Product Portfolio
  102. 7.17.5 East China Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America PROTAC Technology Revenue (2021-2032)
  2. 8.2 North America PROTAC Technology Revenue by Type (2021-2032)
  3. 8.2.1 North America PROTAC Technology Revenue by Type (2021-2026)
  4. 8.2.2 North America PROTAC Technology Revenue by Type (2027-2032)
  5. 8.3 North America PROTAC Technology Revenue Share by Type (2021-2032)
  6. 8.4 North America PROTAC Technology Revenue by Application (2021-2032)
  7. 8.4.1 North America PROTAC Technology Revenue by Application (2021-2026)
  8. 8.4.2 North America PROTAC Technology Revenue by Application (2027-2032)
  9. 8.5 North America PROTAC Technology Revenue Share by Application (2021-2032)
  10. 8.6 North America PROTAC Technology Revenue by Country
  11. 8.6.1 North America PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America PROTAC Technology Revenue by Country (2021-2026)
  13. 8.6.3 North America PROTAC Technology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe PROTAC Technology Revenue (2021-2032)
  2. 9.2 Europe PROTAC Technology Revenue by Type (2021-2032)
  3. 9.2.1 Europe PROTAC Technology Revenue by Type (2021-2026)
  4. 9.2.2 Europe PROTAC Technology Revenue by Type (2027-2032)
  5. 9.3 Europe PROTAC Technology Revenue Share by Type (2021-2032)
  6. 9.4 Europe PROTAC Technology Revenue by Application (2021-2032)
  7. 9.4.1 Europe PROTAC Technology Revenue by Application (2021-2026)
  8. 9.4.2 Europe PROTAC Technology Revenue by Application (2027-2032)
  9. 9.5 Europe PROTAC Technology Revenue Share by Application (2021-2032)
  10. 9.6 Europe PROTAC Technology Revenue by Country
  11. 9.6.1 Europe PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe PROTAC Technology Revenue by Country (2021-2026)
  13. 9.6.3 Europe PROTAC Technology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China PROTAC Technology Revenue (2021-2032)
  2. 10.2 China PROTAC Technology Revenue by Type (2021-2032)
  3. 10.2.1 China PROTAC Technology Revenue by Type (2021-2026)
  4. 10.2.2 China PROTAC Technology Revenue by Type (2027-2032)
  5. 10.3 China PROTAC Technology Revenue Share by Type (2021-2032)
  6. 10.4 China PROTAC Technology Revenue by Application (2021-2032)
  7. 10.4.1 China PROTAC Technology Revenue by Application (2021-2026)
  8. 10.4.2 China PROTAC Technology Revenue by Application (2027-2032)
  9. 10.5 China PROTAC Technology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PROTAC Technology Revenue (2021-2032)
  2. 11.2 Asia PROTAC Technology Revenue by Type (2021-2032)
  3. 11.2.1 Asia PROTAC Technology Revenue by Type (2021-2026)
  4. 11.2.2 Asia PROTAC Technology Revenue by Type (2027-2032)
  5. 11.3 Asia PROTAC Technology Revenue Share by Type (2021-2032)
  6. 11.4 Asia PROTAC Technology Revenue by Application (2021-2032)
  7. 11.4.1 Asia PROTAC Technology Revenue by Application (2021-2026)
  8. 11.4.2 Asia PROTAC Technology Revenue by Application (2027-2032)
  9. 11.5 Asia PROTAC Technology Revenue Share by Application (2021-2032)
  10. 11.6 Asia PROTAC Technology Revenue by Country
  11. 11.6.1 Asia PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia PROTAC Technology Revenue by Country (2021-2026)
  13. 11.6.3 Asia PROTAC Technology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PROTAC Technology Revenue (2021-2032)
  2. 12.2 SAMEA PROTAC Technology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA PROTAC Technology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA PROTAC Technology Revenue by Type (2027-2032)
  5. 12.3 SAMEA PROTAC Technology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA PROTAC Technology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA PROTAC Technology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA PROTAC Technology Revenue by Application (2027-2032)
  9. 12.5 SAMEA PROTAC Technology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA PROTAC Technology Revenue by Country
  11. 12.6.1 SAMEA PROTAC Technology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA PROTAC Technology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA PROTAC Technology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst